High-throughput, computer assisted, specific MetID. A revolution for drug discovery

Drug Discovery Today: Technologies

Volumn 10, Issue 1, 2013, Pages

  Zamora, Ismael ^a   Fontaine, Fabien ^b   Serra, Blanca ^b   Plasencia, Guillem ^a  

^a Lead Molecular Design   (Spain)

^b Molecular Discovery Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD; VERAPAMIL;

ANALYTIC METHOD; CHROMATOGRAPHY; COMPUTER ANALYSIS; DEALKYLATION; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG SYNTHESIS; DRUG TRANSFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; KINETICS; MASS METASITE PROCEDURE; MASS SPECTROMETRY; REVIEW; VALIDATION STUDY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPUTER SIMULATION; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; MASS SPECTROMETRY; MICROSOMES, LIVER; PHARMACEUTICAL PREPARATIONS; REPRODUCIBILITY OF RESULTS; VERAPAMIL;

EID: 84875709453     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2012.10.015     Document Type: Review

References (19)

1. J.W. Cramer Strategies for conducting ADME studies during lead generation in the drug discovery process IDrugs 13 2010 857 861
2. O. Pelkonen, and M. Turpeinen In vitro-in vivo extrapolation of hepatic clearance: biological tools, scaling factors, model assumptions and correct concentrations Xenobiotica 37 2007 1066 1089
3. F.P. Guengerich Mechanisms of drug toxicity and relevance to pharmaceutical development Drug Metab. Pharmacokinet. 26 2011 3 14
4. D.E. Amacher Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies Toxicology 279 2011 10 18
5. Z. Zhang Metabolite identification and profiling in drug design: current practice and future directions Curr. Pharm. Des. 15 2009 2220 2235
6. H. Zhang Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry J. Mass Spectrom. 44 2009 999 1016
7. Y. Hsieh HPLC-MS/MS in drug metabolism and pharmacokinetic screening Expert Opin. Drug Metab. Toxicol. 4 2008 93 101
8. B. Bonn Enhanced metabolite identification with MS(E) and a semi-automated software for structural elucidation Rapid Commun. Mass Spectrom. 24 2010 3127 3138
9. I. Zamora Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9 J. Med. Chem. 46 2003 2313 2324
10. G. Caron Predicting the oxidative metabolism of statins: an application of the MetaSite algorithm Pharm. Res. 24 2007 480 501
11. D. Zhou Comparison of methods for the prediction of the metabolic sites for CYP3A4-mediated metabolic reactions Drug Metab. Dispos. 34 2006 976 983
12. G. Cruciani B. Testa, S. Kraemer, H. Wunderli-Allenspach, G. Folkers, Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical and Computational Strategies 2005 Wiley-VHCA 367
13. G. Cruciani MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist J. Med. Chem. 48 2005 6970 6979
14. J.E. Barbara, and J.M. Castro-Perez High-resolution chromatography/time- of-flight MSE with in silico data mining is an information-rich approach to reactive metabolite screening Rapid Commun. Mass Spectrom. 25 2011 3029 3040
15. A. Makarov, and M. Scigelova Coupling liquid chromatography to Orbitrap mass spectrometry J. Chromatogr. A 1217 2010 3938 3945
16. S. Broecker General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) Forensic Sci. Int. 218 2012 68 81
17. Z. Tozuka Strategy for structural elucidation of drugs and drug metabolites using (MS)n fragmentation in an electrospray ion trap J. Mass Spectrom. 38 2003 793 808
18. T. Rousu Comparison of triple quadrupole, hybrid linear ion trap triple quadrupole, time-of-flight and LTQ-Orbitrap mass spectrometers in drug discovery phase metabolite screening and identification in vitro-amitriptyline and verapamil as model compounds Rapid Commun. Mass Spectrom. 24 2010 939 957
19. G.G. Hopfgartner High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices Anal. Bioanal. Chem. 402 2012 2587 2596